Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Non Operating Income (2021 - 2025)

Historic Non Operating Income for Coeptis Therapeutics Holdings (COEP) over the last 5 years, with Q3 2025 value amounting to -$421735.0.

  • Coeptis Therapeutics Holdings' Non Operating Income fell 23479.34% to -$421735.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 million, marking a year-over-year decrease of 45397.06%. This contributed to the annual value of -$822924.0 for FY2024, which is 46641.49% down from last year.
  • According to the latest figures from Q3 2025, Coeptis Therapeutics Holdings' Non Operating Income is -$421735.0, which was down 23479.34% from -$338460.0 recorded in Q2 2025.
  • In the past 5 years, Coeptis Therapeutics Holdings' Non Operating Income registered a high of $14.2 million during Q1 2021, and its lowest value of -$3.5 million during Q1 2022.
  • Over the past 5 years, Coeptis Therapeutics Holdings' median Non Operating Income value was -$34991.5 (recorded in 2022), while the average stood at $634153.4.
  • Over the last 5 years, Coeptis Therapeutics Holdings' Non Operating Income had its largest YoY gain of 514109.01% in 2023, and its largest YoY loss of 48849.52% in 2023.
  • Quarter analysis of 5 years shows Coeptis Therapeutics Holdings' Non Operating Income stood at $14.2 million in 2021, then tumbled by 99.29% to $100289.0 in 2022, then crashed by 488.5% to -$389618.0 in 2023, then tumbled by 148.75% to -$969170.0 in 2024, then soared by 56.48% to -$421735.0 in 2025.
  • Its Non Operating Income was -$421735.0 in Q3 2025, compared to -$338460.0 in Q2 2025 and $636043.0 in Q1 2025.